Based on in vitro cytological experiments, the targeted knockdown of AURKA in the SK-N-AS cell line could affect the biological behavior of NB cells by inhibiting the mTOR/p70S6K/4E-BP1 signaling pathway. The gene discussed is RPS6KB1; the disease is neuroblastoma.